hydralazine has been researched along with prazosin in 237 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 187 (78.90) | 18.7374 |
| 1990's | 38 (16.03) | 18.2507 |
| 2000's | 7 (2.95) | 29.6817 |
| 2010's | 5 (2.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berridge, TL; Doxey, JC; Gadie, B; Myers, M; Nelson, AJ; Pape, R; Saville, JF; Turner, S | 1 |
| Bandurco, VT; Hajos, ZG; Levine, SD; Wong, EM | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Nies, AS | 1 |
| Oparil, S; Rick, JH | 1 |
| Gifford, RW; Tarazi, RC; Wollam, GL | 1 |
| Wilson, CL; Zacest, R | 1 |
| Sterz, H | 2 |
| Baietti, M; Carletta, C; Liuti, G; Mancinella, A; Paolucci, M | 1 |
| Kuchel, OG; Mahon, WA; McKenzie, JK; Ogilvie, RI | 1 |
| Bertel, O; Bolli, P; Bühler, FR; Kiowski, W; van Brummelen, P | 1 |
| Ibsen, H; Jensen, HA; Leth, A; Rasmussen, K | 1 |
| Sternon, J | 1 |
| Mason, DT | 2 |
| Brundage, BH; Chatterjee, K; Gelberg, H; Massie, B; Ports, TA; Rubin, S | 1 |
| Mathey, D | 1 |
| Brundage, BH; Chatterjee, K; Ports, TA | 1 |
| Halawa, B | 1 |
| Avery, GS; Brogden, RN; Heel, RC; Speight, TM | 1 |
| Lloyd, EA | 1 |
| Buzzeo, LA; Lowenstein, J; Steele, JM | 1 |
| Romankiewicz, JA | 1 |
| Riddiough, MA | 1 |
| Fang, P; Hua, AS; Kincaid-Smith, P; Macdonald, IM; Myers, JB | 1 |
| Awan, NA; Mason, DT; Miller, RR | 1 |
| Meller, J; Packer, M | 1 |
| Hua, AS; Kincaid-Smith, P; Myers, JB | 1 |
| Schumacher, GE | 1 |
| Amsterdam, EA; Awan, N; Mason, DT; Miller, RR | 1 |
| Collier, JG; Lorge, RE; Robinson, BF | 1 |
| Manfrin, M; Prati, PL | 1 |
| Imhof, P | 1 |
| Ryan, C | 1 |
| Imhof, P; Pfister, B | 1 |
| Armstrong, PW | 1 |
| Andersson, KE; Mikkelsen, E; Pedersen, OL | 1 |
| Arnold, S; Brundage, B; Chatterjee, K; Parmley, W; Ports, TA | 1 |
| Conti, CR; Iacona, M; Mehta, J; Pepine, CJ | 1 |
| Cartheuser, CF; Komarek, J | 1 |
| Amsterdam, EA; DeMaria, AN; Laslett, LJ; Mason, DT | 1 |
| Buch, J | 1 |
| Finnerty, FA | 2 |
| Rasmussen, K | 1 |
| Jensen, HA; Rasmussen, K | 1 |
| Grenfell, RF | 1 |
| Graham, RM; Oates, HF; Stokes, GS | 1 |
| Fang, P; Hua, AS; Kincaid-Smith, P; MacDonald, I; Myers, JB | 1 |
| Kelly, JG; Reynolds, GW; Richmond, A; Silke, B; Taylor, SH; Verma, SP | 1 |
| Bhandare, PN; Dhume, VG; Diniz D'Souza, RS; Rataboli, PV | 1 |
| Makó, J; Potyondi, M | 1 |
| Clark, DW; Curzio, JL; Howie, CA; Reid, JL | 1 |
| Janssen, BJ; Struyker-Boudier, HA; Tyssen, CM | 1 |
| Cohn, JN | 6 |
| Lewczuk, J; Wrabec, K | 1 |
| Hsueh, W; Zhang, C | 1 |
| Graham, RM; Ohanian, J; Shen, YT; Vatner, SF; Young, MA | 1 |
| D'Oyley, HM; Pang, CC | 1 |
| Allen, J; Forman, A; Maigaard, S; Skajaa, K | 1 |
| Keeton, TK; Kuo, YJ | 1 |
| Assmann, I | 1 |
| Ogihara, M; Sunaga, K | 1 |
| Bjornson, DC; Daniels, CE; Litman, TJ; Rector, TS; Snowdon, DA; Wertheimer, AI | 1 |
| Imai, S; Nakahara, H; Nakazawa, M; Takeda, K | 1 |
| Leenen, FH | 1 |
| Batts, J; Branche, G; Brown, J; Dowdy, V; King, A; Streets, M | 1 |
| Biediger, AM; Keeton, TK | 1 |
| Moulds, RF | 1 |
| Durando, C; Gessa, M; Leidi, L; Maina, G; Margaria, E; Medaglia, M | 1 |
| Rubin, PC | 1 |
| Akashi, A; Hashimoto, H; Kanda, A; Tanaka, M | 1 |
| Katus, H; Mall, G; Mehls, O; Rambausek, M; Ritz, E | 1 |
| Farkas, RM; Leenen, FH; Marquez-Julio, A; Reeves, RA; Smith, DL | 1 |
| Burkart, F; Kiowski, W | 1 |
| Levine, TB | 2 |
| Franciosa, JA | 1 |
| Ruggie, N | 1 |
| Guyatt, GH | 1 |
| Artman, M; Graham, TP | 1 |
| Leon, CA; Pratt, CM; Young, JB | 1 |
| Brunelle, R; Callaghan, JT; Goldberg, MR | 1 |
| Baez, A; Kaley, G; Panzenbeck, M | 1 |
| Anshelevich, IuV; Dumesh, SZ; Itskovich, VS; Orlova, VP; Raĭbaert, IaIa | 1 |
| Bessegato, L; Dallan, L; de Moraes, AV; Grinberg, M; Higa, SS; Lavítola, Pde L; Pileggi, F; Sosa, EA | 1 |
| Rothlin, ME | 1 |
| Metelitsa, VI; Oganov, RG | 1 |
| Sutton, FJ | 1 |
| Archibald, DG; Cohn, JN; Dunkman, WB; Flohr, KH; Franciosa, JA; Francis, GS; Harston, WE; Jacobs, W; Tristani, FE; Ziesche, S | 2 |
| Izotov, AI; Malysheva, NV; Postol'nikov, SF | 1 |
| Halawa, B; Mazurek, W | 1 |
| Parnell, L; Ramsay, LE; Waller, PC | 1 |
| Kincaid-Smith, P | 1 |
| Ogilvie, RI | 1 |
| Domenech, R; Escobar, E; Jalil, J; Thumala, A; Venegas, P | 1 |
| Friedman, WF; George, BL | 1 |
| Abrams, J | 1 |
| Freis, ED; Kyle, MC | 1 |
| Redgrave, JE; Swartz, SL | 1 |
| Fyhrquist, F; Grönhagen-Riska, C; Karlberg, BE; Ohman, KP; Tikkanen, I | 1 |
| Bing, RF; Russell, GI; Swales, JD; Swart, S; Thurston, H | 1 |
| Petrie, JC | 1 |
| Mashford, ML | 1 |
| Bullen, MU | 1 |
| Scapellato, L; Stornello, M | 1 |
| Marxer, A; Schier, O | 1 |
| Packard, RS | 1 |
| Fischer, E; Siegenthaler, W | 1 |
| Mareev, VIu; Novikov, SV | 1 |
| Shevchenko, VA | 1 |
| Wakade, AR; Wakade, TD | 1 |
| Stevenson, JG; Umstead, GS | 1 |
| McCarron, DA; Pulliam, JP | 1 |
| Bleifeld, W; Mathey, DG | 1 |
| Bartay, J; Benson, D; Peterson, LG | 1 |
| Bodem, G; Ochs, HR | 1 |
| Alexander, RW; Braunwald, E; Colucci, WS; Williams, GH | 1 |
| Graham, RM; Pettinger, WA; Stephenson, WH | 1 |
| Amsterdam, EA; Awan, NA; DeMaria, AN; Joye, JA; Lee, G; Mason, DT | 1 |
| Andersson, O | 1 |
| Bennett, DA; Lal, H | 1 |
| Chatterjee, K; Parmley, WW; Rouleau, JL | 2 |
| Plouin, PF | 1 |
| Medina, N; Packer, M; Yushak, M | 2 |
| Chatterjee, K; Parmley, WW | 2 |
| Romankiewicz, N | 1 |
| Larbig, D; Nasse, H | 1 |
| Barnes, JN; Drew, PJ; Sharman, VL; Vandenburg, MJ; Wright, P | 1 |
| Feldman, R | 1 |
| Beekman, RH; Crowley, DC; Dick, M; Rocchini, AP; Rosenthal, A | 1 |
| Moyer, JH | 1 |
| Ram, CV | 1 |
| Satinsky, JD | 1 |
| Ciafone, RA | 1 |
| Latham, L; Lorimer, AR; McAreavey, D; McLaren, AD; Ramsey, LE; Reid, JL; Robertson, JI; Robertson, MP; Weir, RJ | 1 |
| Gopalaswamy, C; Gould, L | 1 |
| Bertel, O | 1 |
| Bolte, HD | 1 |
| Boucek, MM; Chang, R; Synhorst, DP | 1 |
| Hedley, LR; Strosberg, AM; Van Antwerp, DR | 1 |
| Izotov, AI; Postol'nikov, SF; Vygodin, VA | 1 |
| Jounela, AJ; Karppanen, H; Salmela, PI | 1 |
| Fagerberg, SE; Frithz, G; Malmberg, L | 1 |
| Julius, S; Osterziel, KJ | 1 |
| Taylor, SH | 1 |
| Khomenko, VL; Pomerantsev, VP; Vasiuk, IuA | 1 |
| Franciosa, JA; Pierpont, G | 1 |
| Robinson, PH; Wagner, GC | 1 |
| Baigrie, R; Burns, R; Feiglin, D; Haq, A; Hilton, D; McLaughlin, P; Rakowski, H; Tihal, H | 1 |
| Deglin, SM; Mandell, HN | 1 |
| Rutishauser, W | 1 |
| White, SJ; Williamson, K | 1 |
| Chatterjee, K; Massie, BM; Rouleau, JL | 1 |
| Dyer, RD; Huttner, JJ; Mulrow, PJ; Tan, SY | 1 |
| Berkowitz, RL | 1 |
| Melkild, A | 1 |
| Freed, CR; Gerber, JG; Nies, AS | 1 |
| Fossati, C | 1 |
| Croveri, G; Lucignani, P | 1 |
| Chatterjee, K; Rouleau, JL | 1 |
| Benge, W; Chatterjee, K; Hiramatsu, B; Parmley, WW; Rouleau, JL | 1 |
| Gasanova, AS; Serbin, VI | 1 |
| Covell, JW; Engler, R; Link, J; Pouleur, H; Printz, M | 1 |
| Reisman, L; Selden, RV | 1 |
| Bing, RF; Heagerty, AM; Russell, GI; Swales, JD; Thurston, H | 1 |
| Pruitt, AW | 1 |
| Baum, T; Moran, RM; Sabin, C | 1 |
| Persson, B; Thorén, P; Yao, T | 1 |
| Elkayam, U; Frishman, W; LeJemtel, T; Mathur, M; Sonnenblick, EH; Strom, J | 1 |
| Bay, WH; Desch, CE; Leier, CV; Magorien, RD; Triffon, DW; Unverferth, DV | 1 |
| Graziani, G; Griffini, P; Luca, C | 1 |
| Carù, B; Cataldo, G; Faletra, F; Ferrari, D; Gronda, E; Mafrici, A; Mauri, F; Pirelli, S; Salvadè, P | 1 |
| Packer, M | 1 |
| Atkins, FL | 1 |
| Segal, BL | 1 |
| Chatterjee, K; Parmley, WW; Rubin, SA | 1 |
| Greenberg, BH; Massie, BM | 1 |
| Cabaniss, CD | 1 |
| Gavras, H; Gavras, I | 1 |
| Despas, P; Fitchett, DH; Pardy, R; Pathé, M | 1 |
| Bannan, LT; Beevers, DG; Wright, N | 1 |
| Jones, JV; Steiner, JM | 1 |
| Boudoulas, H; Desch, CE; Leier, CV; Lewis, RP; Magorien, RD; Triffon, DW; Unverferth, DV | 1 |
| Himmler, FC; Klein, G; Kutschera, I; Sauer, E; Schmidt, G; Wirtzfeld, A | 1 |
| Anciones, B; Arnalich, F; García Puig, J; Gaspar, G; Gil Aguado, A; Vázquez, JJ | 1 |
| Shapiro, AP; Traub, YM | 1 |
| Elkayam, U | 1 |
| Burney, IA; Field, SB; Griffiths, JR; Maxwell, RJ; McCoy, CL | 1 |
| Annuzzi, G; D'Orta, G; Di Marino, L; Ferrara, LA; Lucarelli, C; Mancini, M; Marotta, T; Rossi, F; Russo, O | 1 |
| Hajj-Ali, AF; Reilly, TM; Wong, PC | 1 |
| Battell, ML; Grassby, PF; Lee, SY; McNeill, JH; Rodrigues, B | 1 |
| Fehér, J; Gachályi, B; Juhász, I; Székács, B | 1 |
| Brecher, P; Chobanian, AV; Crawford, DC; Himeno, H; Hosoi, M | 1 |
| Carson, PE; Cohn, JN; Dunkman, WB; Farrell, L; Fletcher, RD; Johnson, GR | 1 |
| Cohn, JN; Hughes, CV; Johnson, G; Wong, M | 1 |
| Cintron, G; Cobb, F; Cohn, JN; Francis, G; Johnson, G | 1 |
| Cintron, G; Cohn, JN; Francis, G; Goldman, S; Johnson, G; Smith, R | 1 |
| Cohn, JN; Fletcher, R; Johnson, GR; Loeb, H; Rector, T; Shabetai, R; Smith, R; Tristani, F | 1 |
| Cobb, FR; Cohn, JN; Johnson, G; Tristani, F; Ziesche, S | 1 |
| Bhat, G; Cohn, JN; Hughes, V; Johnson, G; Lopez, B; Shabetai, R; Wong, M | 1 |
| Cohn, JN; Cremo, R; Henrick, A; Johnson, G; Loeb, HS; Smith, R; Wilson, J | 1 |
| Bhat, G; Carson, PE; Cohn, JN; Dunkman, WB; Farrell, L; Johnson, GR | 1 |
| Ball, WA; Gresch, PJ; Morrison, AR; Ross, RJ; Sanford, LD | 1 |
| Cabell, KS; Johnson, P; Ma, L | 1 |
| Takahashi, M; Uehara, Y | 1 |
| de los Angeles Sánchez-Salvatori, M; Ríos, C; Vidrio, H | 1 |
| Adigun, AQ; Ajayi, AA; Ajayi, OE; Sofowora, GG | 1 |
| Li, J; Wang, DH | 1 |
| Baudrie, V; Elghozi, JL; Laude, D | 2 |
| Ehtisham, S; Hashmi, HA | 1 |
| Ayajiki, K; Funai, A; Kobuchi, S; Matsumura, Y; Ohkita, M; Suzuki, R; Tanaka, R; Tsutsui, H; Yazawa, M | 1 |
46 review(s) available for hydralazine and prazosin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Clinical pharmacology of antihypertensive drugs.
Topics: Adrenergic alpha-Antagonists; Aldosterone; Angiotensin II; Antihypertensive Agents; Bethanidine; Blood Pressure; Clonidine; Diazoxide; Diuretics; Emergencies; Guanethidine; Humans; Hydralazine; Hypertension; Methyldopa; Minoxidil; Monoamine Oxidase Inhibitors; Nitroprusside; Prazosin; Propranolol; Renin; Reserpine; Sympathetic Nervous System; Trimethaphan | 1977 |
Antihypertensive drugs: clinical pharmacology and therapeutic use.
Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Clonidine; Diazoxide; Diuretics; Ganglionic Blockers; Humans; Hydralazine; Hypertension; Labetalol; Methyldopa; Minoxidil; Monoamine Oxidase Inhibitors; Nitroprusside; Potassium; Prazosin; Secologanin Tryptamine Alkaloids; Sympatholytics | 1977 |
[New aspects in the treatment of acute cardiac insufficiency].
Topics: Adrenergic beta-Antagonists; Clonidine; Diazoxide; Digitalis Glycosides; Diuretics; Droperidol; Fentanyl; Fibrinolytic Agents; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Microcirculation; Myocardial Contraction; Neuroleptanalgesia; Nitroprusside; Phentolamine; Prazosin; Respiration, Artificial; Vascular Resistance; Vasodilator Agents | 1978 |
Afterload reduction and cardiac performance. Physiologic basis of systemic vasodilators as a new approach in treatment of congestive heart failure.
Topics: Aorta; Cardiac Output; Chronic Disease; Heart; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Hydralazine; Myocardial Infarction; Nitroglycerin; Nitroprusside; Prazosin; Pressure; Research; Vascular Resistance; Vasodilator Agents | 1978 |
[Use of vasodilator agents in circulatory insufficienty].
Topics: Blood Circulation; Dihydralazine; Heart Failure; Humans; Hydralazine; Nitrates; Nitroglycerin; Nitroprusside; Prazosin; Quinazolines; Vasodilator Agents | 1979 |
Prazosin: a review of its pharmacological properties and therapeutic efficacy in hypertension.
Topics: Animals; Benzothiadiazines; Blood Pressure; Clinical Trials as Topic; Diuretics; Drug Eruptions; Drug Therapy, Combination; Heart Rate; Humans; Hydralazine; Hypertension; Kidney; Kidney Diseases; Kinetics; Methyldopa; Prazosin; Quinazolines; Renin; Sodium Chloride Symporter Inhibitors; Time Factors | 1977 |
The use of vasodilator agents in the treatment of heart failure.
Topics: Cardiac Output; Cardiomegaly; Catheterization; Chronic Disease; Coronary Vessels; Dose-Response Relationship, Drug; Heart Failure; Heart Valve Diseases; Hemodynamics; Humans; Hydralazine; Myocardial Infarction; Nitrates; Nitroprusside; Oxygen Consumption; Prazosin; Stroke Volume; Vasodilation; Vasodilator Agents | 1979 |
Preventing, detecting and managing adverse reactions of antihypertensive agents in the ambulant patient with essential hypertension.
Topics: Antihypertensive Agents; Benzothiadiazines; Clonidine; Diuretics; Drug Interactions; Ethacrynic Acid; Furosemide; Guanethidine; Humans; Hydralazine; Hypertension; Methyldopa; Minoxidil; Prazosin; Propranolol; Reserpine; Sodium Chloride Symporter Inhibitors; Spironolactone | 1977 |
Afterload reduction in the management of congestive heart failure following acute myocardial infarction.
Topics: Acute Disease; Dopamine; Heart Failure; Hemodynamics; Humans; Hydralazine; Myocardial Infarction; Nitrates; Nitroprusside; Prazosin; Vasodilator Agents | 1978 |
Oral vasodilator therapy for chronic heart failure: a plea for caution.
Topics: Cardiac Output; Chronic Disease; Forecasting; Heart Failure; Humans; Hydralazine; Nitrates; Prazosin; Vascular Resistance; Vasodilator Agents | 1978 |
Using pharmacokinetics in drug therapy. V: Contributions to developing dosage regimens for antihypertensive drugs.
Topics: Antihypertensive Agents; Clonidine; Drug Administration Schedule; Guanethidine; Humans; Hydralazine; Kinetics; Methyldopa; Minoxidil; Prazosin; Propranolol | 1979 |
[Vasodilator agents in the treatment of heart failure].
Topics: Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Minoxidil; Nitroglycerin; Nitroprusside; Phentolamine; Prazosin; Vasodilator Agents | 1978 |
[Treatment of cardiac failure with vasodilators (author's transl)].
Topics: Cardiac Glycosides; Diuretics; Drug Therapy, Combination; Heart Failure; Hydralazine; Hypotension; Isosorbide Dinitrate; Nitroglycerin; Nitroprusside; Phenoxybenzamine; Phentolamine; Prazosin; Vasodilator Agents | 1978 |
Lessons from V-HeFT: questions for V-HeFT II and the future therapy of heart failure.
Topics: Enalapril; Heart Failure; Hemodynamics; Humans; Hydralazine; Isosorbide Dinitrate; Prazosin; Survival Rate; Vasodilator Agents | 1991 |
[Value of vasodilator agents in the treatment of diseases with pulmonary hypertension caused by chronic obstructive lung diseases].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Drug Evaluation; Humans; Hydralazine; Hypertension, Pulmonary; Lung Diseases, Obstructive; Piperazines; Prazosin; Pulmonary Heart Disease; Vasodilator Agents | 1991 |
[The extension of heart failure therapy with vasodilators].
Topics: Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Drug Therapy, Combination; Heart Failure; Humans; Hydralazine; Nitrates; Prazosin; Vasodilator Agents | 1990 |
Treatment of hypertension in pregnancy.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Diazoxide; Diuretics; Eclampsia; Female; Humans; Hydralazine; Hypertension; Methyldopa; Nitroprusside; Prazosin; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular | 1986 |
Congestive heart failure.
Topics: Aminopyridines; Amrinone; Angiotensin-Converting Enzyme Inhibitors; Cardiac Glycosides; Cardiotonic Agents; Diuretics; Dobutamine; Dopamine; Heart Failure; Humans; Hydralazine; Milrinone; Nitrates; Nitroprusside; Prazosin; Pyridones; Sympathomimetics; Vasodilator Agents | 1986 |
The treatment of heart failure. A methodological review of the literature.
Topics: Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Clinical Trials as Topic; Digoxin; Diuretics; Heart Diseases; Humans; Hydralazine; Nitrates; Piperazines; Prazosin; Pyridines; Research Design | 1986 |
Potentially deleterious effects of long-term vasodilator therapy in patients with heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Heart; Heart Failure; Hemodynamics; Humans; Hydralazine; Minoxidil; Prazosin; Pulmonary Wedge Pressure; Time Factors; Vasodilator Agents | 1987 |
Vasodilators for chronic congestive heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Drug Therapy, Combination; Heart Failure; Humans; Hydralazine; Nitrates; Prazosin; Vasodilator Agents | 1988 |
Vasodilator therapy.
Topics: Administration, Oral; Captopril; Cardiac Output; Dose-Response Relationship, Drug; Double-Blind Method; Heart Failure; Hemodynamics; Humans; Hydralazine; Nitrates; Physical Exertion; Prazosin; Random Allocation; Stroke Volume; Time Factors; Vasodilator Agents | 1986 |
Vasodilator drugs in the treatment of hypertension.
Topics: Calcium Channel Blockers; Captopril; Cardiac Output; Diazoxide; Diuretics; Dose-Response Relationship, Drug; Drug Therapy, Combination; Hemodynamics; Humans; Hydralazine; Hypertension; Infusions, Parenteral; Minoxidil; Prazosin; Renal Circulation; Vasodilator Agents | 1985 |
Current concepts in the treatment of congestive heart failure.
Topics: Calcium Channel Blockers; Captopril; Digitalis Glycosides; Dipeptides; Diuretics; Enalapril; Enzyme Inhibitors; Heart Failure; Humans; Hydralazine; Hypernatremia; Isosorbide Dinitrate; Nitroprusside; Prazosin; Vasoconstriction | 1984 |
[Bases of pharmacological therapy of essential hypertension].
Topics: Adrenergic beta-Antagonists; Adult; Age Factors; Aged; Antihypertensive Agents; Captopril; Clonidine; Diuretics; Guanethidine; Humans; Hydralazine; Hypertension; Methyldopa; Middle Aged; Minoxidil; Monoamine Oxidase Inhibitors; Prazosin; Secologanin Tryptamine Alkaloids | 1980 |
Antihypertensive agents 1969-1980.
Topics: Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Captopril; Clonidine; Ergolines; Fusaric Acid; Guanidines; Humans; Hydralazine; Indoramin; Methyldopa; Minoxidil; Nifedipine; Piperazines; Prazosin; Prostaglandins | 1981 |
Prazosin: a review of clinical experience in hypertension.
Topics: Adrenergic beta-Antagonists; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Diuretics; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Drug Tolerance; Glomerular Filtration Rate; Humans; Hydralazine; Hypertension; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Prazosin; Quinazolines; Vascular Resistance | 1981 |
[Adrenergic alpha-receptor blockaders and direct arteriolar vasodilators in treatment of chronic cardiac insufficiency].
Topics: Adrenergic alpha-Antagonists; Arterioles; Cardiac Output, Low; Chronic Disease; Hemodynamics; Humans; Hydralazine; Phentolamine; Prazosin; Tropanes; Vasodilator Agents | 1983 |
[Treatment of heart failure in ischemic heart disease with beta-adrenostimulators and peripheral vasodilators].
Topics: Adrenergic beta-Agonists; Captopril; Cardiotonic Agents; Coronary Disease; Dobutamine; Dopamine; Heart Failure; Humans; Hydralazine; Isoproterenol; Isosorbide Dinitrate; Nitroprusside; Nonachlazine; Phentolamine; Practolol; Prazosin; Prenalterol; Vasodilator Agents | 1983 |
Mechanisms and implications of vasodilator tolerance in the treatment of congestive heart failure.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Angiotensin-Converting Enzyme Inhibitors; Drug Tolerance; Enzyme Inhibitors; Heart Failure; Humans; Hydralazine; Nitrates; Nitroprusside; Oligopeptides; Parasympatholytics; Phenoxybenzamine; Phentolamine; Prazosin; Teprotide; Vasodilator Agents | 1981 |
Drug systems approach to hypertension.
Topics: Captopril; Clonidine; Drug Combinations; Drug Therapy, Combination; Guanethidine; Humans; Hydralazine; Hydrochlorothiazide; Hypertension; Hypertension, Malignant; Methyldopa; Patient Compliance; Prazosin; Proteinuria; Renin-Angiotensin System; Reserpine; Spironolactone | 1984 |
Hypertensive crisis.
Topics: Antihypertensive Agents; Brain Diseases; Cerebrovascular Disorders; Clonidine; Coronary Disease; Diazoxide; Eclampsia; Emergencies; Female; Humans; Hydralazine; Hypertension; Hypertension, Malignant; Labetalol; Minoxidil; Nifedipine; Nitroprusside; Phentolamine; Prazosin; Pregnancy; Pulmonary Edema; Trimethaphan | 1984 |
[Vasodilator agents in the treatment of cardiac insufficiency].
Topics: Captopril; Dihydralazine; Heart Failure; Humans; Hydralazine; Nitroglycerin; Nitroprusside; Phentolamine; Prazosin; Vasodilator Agents | 1984 |
[Treatment of heart failure with vasodilators].
Topics: Captopril; Cardiomegaly; Cardiotonic Agents; Coronary Disease; Heart Failure; Heart Function Tests; Heart Valve Diseases; Humans; Hydralazine; Nitroglycerin; Phentolamine; Prazosin; Vasodilator Agents | 1980 |
Vasodilator therapy for chronic heart failure.
Topics: Captopril; Chronic Disease; Heart Failure; Hemodynamics; Humans; Hydralazine; Nitrates; Nitroglycerin; Physical Exertion; Prazosin; Vasodilator Agents | 1980 |
[Peripheral vasodilator agents in cardiology].
Topics: Clinical Trials as Topic; Coronary Vessels; Heart Failure; Hemodynamics; Humans; Hydralazine; Myocardial Infarction; Nitrates; Nitroglycerin; Nitroprusside; Phentolamine; Piperazines; Prazosin; Quinazolines; Vasodilator Agents | 1980 |
Vasodilator therapy of congestive heart failure.
Topics: Aortic Valve Insufficiency; Captopril; Dobutamine; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Minoxidil; Mitral Valve Insufficiency; Nitroglycerin; Nitroprusside; Phentolamine; Physical Exertion; Piperazines; Prazosin; Quinazolines; Time Factors; Vasodilator Agents | 1980 |
Cardiovascular clinical pharmacology of impedance reducing agents.
Topics: Heart Failure; Humans; Hydralazine; Nitrates; Nitroglycerin; Nitroprusside; Phentolamine; Prazosin; Vasodilator Agents | 1981 |
Anti-hypertensive drugs in the pregnant patient.
Topics: Antihypertensive Agents; Chronic Disease; Clonidine; Diazoxide; Diuretics; Female; Fetus; Furosemide; Guanethidine; Humans; Hydralazine; Hypertension; Infant Mortality; Methyldopa; Nitroprusside; Prazosin; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Propranolol; Secologanin Tryptamine Alkaloids; Sodium; Sodium Chloride Symporter Inhibitors | 1980 |
Antihypertensive pharmacology.
Topics: Adolescent; Adult; Antihypertensive Agents; Clonidine; Diazoxide; Diuretics; Guanethidine; Humans; Hydralazine; Hypertension; Methyldopa; Metoprolol; Minoxidil; Nitroprusside; Patient Compliance; Prazosin; Propranolol; Reserpine; Sodium Chloride Symporter Inhibitors | 1980 |
[Therapy of essential arterial hypertension. III].
Topics: Antihypertensive Agents; Humans; Hydralazine; Hypertension; Minoxidil; Prazosin; Reserpine; Vasodilator Agents | 1980 |
[Arterial hypertension, III. Antihypertensive therapy (1). Diuretics].
Topics: Antihypertensive Agents; Diazoxide; Diuretics; Humans; Hydralazine; Hypertension; Mineralocorticoid Receptor Antagonists; Minoxidil; Prazosin; Sodium Chloride Symporter Inhibitors; Vasodilator Agents | 1980 |
[Peripheral vasodilators in the treatment of heart failure].
Topics: Cardiac Output; Cardiomyopathies; Coronary Circulation; Droperidol; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Nitrates; Nitroprusside; Phentolamine; Piperazines; Prazosin; Quinazolines; Rheumatic Heart Disease; Stroke Volume; Vasodilator Agents | 1982 |
Management of systemic hypertension in children.
Topics: Adolescent; Antihypertensive Agents; Child; Clonidine; Diazoxide; Diet, Sodium-Restricted; Diuretics; Humans; Hydralazine; Hypertension; Methyldopa; Minoxidil; Nitroprusside; Prazosin; Propranolol | 1982 |
Left ventricle and arteries: structure, function, hormones, and disease.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Arginine Vasopressin; Drug Combinations; Epinephrine; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Nitroprusside; Prazosin; Randomized Controlled Trials as Topic; Renin; Renin-Angiotensin System; Stroke Volume; Survival Analysis; Time Factors; Vasodilator Agents; Ventricular Dysfunction, Left; Ventricular Remodeling | 2001 |
42 trial(s) available for hydralazine and prazosin
| Article | Year |
|---|---|
Antihypertensive efficacy of a new long acting hydralazine like vasodilator, ISF 2469 in combination with a betablocker and a diuretic.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Antihypertensive Agents; Blood Pressure; Clinical Trials as Topic; Diuretics; Drug Therapy, Combination; Female; Humans; Hydralazine; Hydrazines; Hypertension; Male; Middle Aged; Prazosin; Pyridazines; Vasodilator Agents | 1979 |
Prazosin: a review of its pharmacological properties and therapeutic efficacy in hypertension.
Topics: Animals; Benzothiadiazines; Blood Pressure; Clinical Trials as Topic; Diuretics; Drug Eruptions; Drug Therapy, Combination; Heart Rate; Humans; Hydralazine; Hypertension; Kidney; Kidney Diseases; Kinetics; Methyldopa; Prazosin; Quinazolines; Renin; Sodium Chloride Symporter Inhibitors; Time Factors | 1977 |
Studies with prazosin--a new effective hypotensive agent. II. Two double-blind cross-over studies comparing the effects of prazosin and hydrallazine.
Topics: Adult; Chlorothiazide; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydralazine; Hypertension; Male; Middle Aged; Prazosin; Propranolol; Quinazolines | 1977 |
Studies with prazosin--a new effective hypotensive agent. III. An acute double-blind cross-over study comparing the effects of single doses of prazosin and hydrallazine in combination with propranolol and a diuretic.
Topics: Adult; Aged; Benzothiadiazines; Blood Pressure; Clinical Trials as Topic; Diuretics; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydralazine; Hypertension; Male; Middle Aged; Posture; Prazosin; Propranolol; Pulse; Quinazolines; Sodium Chloride Symporter Inhibitors | 1978 |
A cross-over study between hydrallazine and prazosin.
Topics: Clinical Trials as Topic; Humans; Hydralazine; Hypertension; Prazosin; Propranolol; Quinazolines | 1976 |
Prazosin and hydrallazine in the treatment of hypertension.
Topics: Heart Rate; Humans; Hydralazine; Hypertension; Prazosin; Quinazolines; Time Factors | 1976 |
Statistical significance of Veterans Administration Vasodilator Heart Failure Trial results.
Topics: Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Prazosin; Research Design; Statistics as Topic; United States; United States Department of Veterans Affairs | 1990 |
Vasodilators and regression of left ventricular hypertrophy. Hydralazine versus prazosin in hypertensive humans.
Topics: Adult; Cardiomegaly; Female; Humans; Hydralazine; Hypertension; Male; Middle Aged; Prazosin; Vasodilator Agents | 1987 |
Role of vasodilators in the treatment of congestive heart failure.
Topics: Captopril; Clinical Trials as Topic; Dipeptides; Double-Blind Method; Enalapril; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Prazosin; Random Allocation; Regional Blood Flow; Vascular Resistance; Vasodilator Agents | 1985 |
The treatment of heart failure. A methodological review of the literature.
Topics: Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Clinical Trials as Topic; Digoxin; Diuretics; Heart Diseases; Humans; Hydralazine; Nitrates; Piperazines; Prazosin; Pyridines; Research Design | 1986 |
Effect of vasodilator therapy on mortality in chronic congestive heart failure.
Topics: Clinical Trials as Topic; Drug Therapy, Combination; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Prazosin; Random Allocation | 1988 |
Double-blind comparator trials with pinacidil, a potassium channel opener.
Topics: Antihypertensive Agents; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Guanidines; Heart Rate; Humans; Hydralazine; Hypertension; Methyldopa; Middle Aged; Pinacidil; Potassium Channels; Prazosin; Random Allocation | 1988 |
[Comparative study of vasodilator drugs in heart valve diseases].
Topics: Adolescent; Adult; Aortic Valve Insufficiency; Clinical Trials as Topic; Echocardiography; Female; Hemodynamics; Humans; Hydralazine; Isosorbide Dinitrate; Male; Middle Aged; Mitral Valve Insufficiency; Prazosin; Vasodilator Agents | 1987 |
Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study.
Topics: Clinical Trials as Topic; Drug Therapy, Combination; Exercise Test; Follow-Up Studies; Heart Failure; Hemodynamics; Humans; Hydralazine; Isosorbide Dinitrate; Male; Middle Aged; Prazosin; Random Allocation; Vasodilator Agents | 1986 |
[Endralazine monotherapy in comparison with prazosin and hydralazine in arterial hypertension].
Topics: Adult; Clinical Trials as Topic; Humans; Hydralazine; Hypertension; Male; Middle Aged; Prazosin; Pyridazines | 1986 |
Veterans Administration Cooperative Study on Vasodilator Therapy of Heart Failure: influence of prerandomization variables on the reduction of mortality by treatment with hydralazine and isosorbide dinitrate.
Topics: Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Male; Middle Aged; Prazosin; Prognosis; Random Allocation | 1987 |
Comparison of nifedipine, prazosin and hydralazine added to treatment of hypertensive patients uncontrolled by thiazide diuretic plus beta-blocker.
Topics: Adult; Aged; Atenolol; Bendroflumethiazide; Blood Pressure; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Hydralazine; Hypertension; Male; Middle Aged; Nifedipine; Prazosin; Random Allocation | 1987 |
Enalapril and lisinopril in renovascular hypertension--antihypertensive and hormonal effects of two new angiotensin-converting-enzyme (ACE) inhibitors. A preliminary report.
Topics: Adult; Aged; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Dipeptides; Enalapril; Humans; Hydralazine; Hypertension, Renovascular; Lisinopril; Middle Aged; Prazosin | 1984 |
[Long-term drug treatment of chronic heart failure].
Topics: Adrenergic beta-Antagonists; Captopril; Heart Failure; Hemodynamics; Humans; Hydralazine; Nitroglycerin; Physical Exertion; Prazosin; Prognosis; Regional Blood Flow; Renal Circulation | 1984 |
Hydralazine and prazosin in the treatment of hypertension.
Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Drug Therapy, Combination; Female; Heart Rate; Humans; Hydralazine; Hypertension; Male; Middle Aged; Prazosin; Quinazolines | 1983 |
"Third drug" trial: comparative study of antihypertensive agents added to treatment when blood pressure remains uncontrolled by a beta blocker plus thiazide diuretic.
Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Blood Pressure; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Hydralazine; Hypertension; Labetalol; Male; Methyldopa; Middle Aged; Minoxidil; Prazosin | 1984 |
[Methodologic approach to individual evaluation of the pharmacodynamic effects of single doses of hydralazine, endralazine, prazosine and propranolol in hypertension patients].
Topics: Adult; Antihypertensive Agents; Cardiac Output; Cardiography, Impedance; Humans; Hydralazine; Hypertension; Kinetics; Middle Aged; Prazosin; Propranolol; Pyridazines; Vascular Resistance | 1984 |
Double-blind comparison of dihydralazine and prazosin in hypertensive patients on the diuretic-reserpine regimen.
Topics: Adult; Aged; Clinical Trials as Topic; Dihydralazine; Double-Blind Method; Female; Humans; Hydralazine; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Norepinephrine; Prazosin; Quinazolines; Renin; Reserpine; Triamterene | 1981 |
Peripheral vasodilatation in the treatment of hypertension. Prazosin compared with hydralazine in patients not responding to beta-receptor blockade.
Topics: Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; Female; Humans; Hydralazine; Hypertension; Male; Middle Aged; Prazosin; Propranolol; Quinazolines; Random Allocation; Vasodilator Agents | 1982 |
[Peripheral vasodilator agents in cardiology].
Topics: Clinical Trials as Topic; Coronary Vessels; Heart Failure; Hemodynamics; Humans; Hydralazine; Myocardial Infarction; Nitrates; Nitroglycerin; Nitroprusside; Phentolamine; Piperazines; Prazosin; Quinazolines; Vasodilator Agents | 1980 |
[Cross-over trial with Peripress (prazosin) and Apresolin (hydralazin), both in combination with beta-blocker].
Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Cross-Sectional Studies; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Hydralazine; Hypertension; Male; Middle Aged; Prazosin; Propranolol; Pulse; Quinazolines | 1980 |
Comparison of prazosin with hydralazine in patients receiving hydrochlorothiazide. A randomized, double-blind clinical trial.
Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Humans; Hydralazine; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Prazosin; Pulse; Quinazolines; Random Allocation | 1981 |
Alterations in left ventricular function and coronary hemodynamics with captopril, hydralazine and prazosin in chronic ischemic heart failure: a comparative study.
Topics: Aged; Captopril; Coronary Disease; Dose-Response Relationship, Drug; Heart Failure; Hemodynamics; Humans; Hydralazine; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction; Prazosin; Proline; Quinazolines | 1982 |
Double-blind cross-over comparison of hydralazine and prazosin in hypertensive subjects on a beta-adrenoceptor blocking agent (atenolol).
Topics: Atenolol; Double-Blind Method; Drug Therapy, Combination; Humans; Hydralazine; Hypertension; Prazosin; Propanolamines; Quinazolines | 1980 |
[Orally active vasodilators in the management of chronic treatment-resistant cardiac failure (author's transl)].
Topics: Adult; Aged; Dihydralazine; Heart Failure; Hemodynamics; Humans; Hydralazine; Isosorbide Dinitrate; Middle Aged; Prazosin; Quinazolines | 1980 |
Factors affecting lipoprotein lipase in hypertensive patients.
Topics: Blood Pressure; Drug Therapy, Combination; Female; Humans; Hydralazine; Hypertension; Insulin; Lipids; Lipoprotein Lipase; Male; Middle Aged; Placebos; Prazosin; Propranolol | 1995 |
The Vasodilator-Heart Failure Trials (V-HeFT). Mechanistic data from the VA Cooperative Studies. Introduction.
Topics: Drug Therapy, Combination; Enalapril; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Male; Prazosin; Research Design; Survival Analysis; Vasodilator Agents | 1993 |
The influence of atrial fibrillation on prognosis in mild to moderate heart failure. The V-HeFT Studies. The V-HeFT VA Cooperative Studies Group.
Topics: Atrial Fibrillation; Drug Therapy, Combination; Enalapril; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Male; Middle Aged; Morbidity; Prazosin; Prognosis; Risk Factors | 1993 |
Influence of age on mechanisms and prognosis of heart failure. The V-HeFT VA Cooperative Studies Group.
Topics: Age Factors; Aged; Drug Therapy, Combination; Enalapril; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Male; Middle Aged; Prazosin; Prognosis; Survival Analysis | 1993 |
Prognostic significance of serial changes in left ventricular ejection fraction in patients with congestive heart failure. The V-HeFT VA Cooperative Studies Group.
Topics: Drug Therapy, Combination; Enalapril; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Male; Middle Aged; Prazosin; Prognosis; Stroke Volume; Survival Analysis; Ventricular Function, Left | 1993 |
Mechanism of death in heart failure. The Vasodilator-Heart Failure Trials. The V-HeFT VA Cooperative Studies Group.
Topics: Cause of Death; Death, Sudden, Cardiac; Drug Therapy, Combination; Enalapril; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Male; Middle Aged; Prazosin; Risk Factors; Survival Analysis | 1993 |
Ejection fraction, peak exercise oxygen consumption, cardiothoracic ratio, ventricular arrhythmias, and plasma norepinephrine as determinants of prognosis in heart failure. The V-HeFT VA Cooperative Studies Group.
Topics: Arrhythmias, Cardiac; Cardiomegaly; Drug Therapy, Combination; Enalapril; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Male; Middle Aged; Norepinephrine; Oxygen Consumption; Prazosin; Prognosis; Stroke Volume; Ventricular Function, Left | 1993 |
Hydralazine and isosorbide dinitrate combination improves exercise tolerance in heart failure. Results from V-HeFT I and V-HeFT II. The V-HeFT VA Cooperative Studies Group.
Topics: Anaerobic Threshold; Drug Therapy, Combination; Enalapril; Exercise Test; Exercise Tolerance; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Male; Middle Aged; Prazosin | 1993 |
Echocardiographic variables as prognostic indicators and therapeutic monitors in chronic congestive heart failure. Veterans Affairs cooperative studies V-HeFT I and II. V-HeFT VA Cooperative Studies Group.
Topics: Drug Therapy, Combination; Echocardiography; Enalapril; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Male; Middle Aged; Prazosin; Survival Analysis; Ventricular Function, Left | 1993 |
Effect of enalapril, hydralazine plus isosorbide dinitrate, and prazosin on hospitalization in patients with chronic congestive heart failure. The V-HeFT VA Cooperative Studies Group.
Topics: Drug Therapy, Combination; Enalapril; Heart Failure; Hospitalization; Humans; Hydralazine; Isosorbide Dinitrate; Male; Middle Aged; Prazosin; Risk Factors; Time Factors | 1993 |
Incidence of thromboembolic events in congestive heart failure. The V-HeFT VA Cooperative Studies Group.
Topics: Cerebrovascular Disorders; Drug Therapy, Combination; Enalapril; Heart Failure; Humans; Hydralazine; Incidence; Isosorbide Dinitrate; Male; Middle Aged; Platelet Aggregation Inhibitors; Prazosin; Thromboembolism; Warfarin | 1993 |
Vasodilator therapy of hypertensive acute left ventricular failure: comparison of captopril-prazosin with hydralazine-isosorbide dinitrate.
Topics: Adult; Antihypertensive Agents; Captopril; Drug Therapy, Combination; Female; Humans; Hydralazine; Hypertension; Isosorbide Dinitrate; Male; Middle Aged; Prazosin; Prospective Studies; Single-Blind Method; Vasodilator Agents; Ventricular Dysfunction, Left | 1998 |
152 other study(ies) available for hydralazine and prazosin
| Article | Year |
|---|---|
Antihypertensive thiadiazoles. 1. Synthesis of some 2-aryl-5-hydrazino-1,3,4-thiadiazoles with vasodilator activity.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Decerebrate State; Hydrazines; Hypertension; Male; Muscle, Smooth, Vascular; Rats; Rats, Inbred Strains; Structure-Activity Relationship; Thiadiazoles | 1988 |
Antihypertensive pyrrolo[1,2-c]quinazolines and pyrrolo[1,2-c]quinazolinones.
Topics: Animals; Antihypertensive Agents; Male; Quinazolines; Rats; Structure-Activity Relationship | 1981 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Drug treatment of hypertension.
Topics: Clonidine; Diazoxide; Diuretics; Ganglionic Blockers; Guanethidine; Humans; Hydralazine; Hypertension; Mecamylamine; Methyldopa; Mineralocorticoid Receptor Antagonists; Minoxidil; Nitroprusside; Prazosin; Propranolol; Secologanin Tryptamine Alkaloids; Sodium Chloride Symporter Inhibitors; Spironolactone; Sympatholytics; Triamterene; Trimethaphan; Vasodilator Agents | 1977 |
Hydrallazine and prazosin.
Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Humans; Hydralazine; Hypertension; Prazosin; Quinazolines | 1978 |
[Treatment of arterial hypertension in the aged].
Topics: Adrenergic beta-Antagonists; Age Factors; Aged; Antihypertensive Agents; Clonidine; Diuretics; Humans; Hydralazine; Hypertension; Hypertension, Renovascular; Methyldopa; Prazosin; Prostaglandins, Synthetic; Reserpine | 1978 |
Approach to drug therapy for hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Antihypertensive Agents; Benzothiadiazines; Clonidine; Diuretics; Guanidines; Humans; Hydralazine; Hypertension; Methyldopa; Middle Aged; Patient Care Planning; Patient Compliance; Prazosin; Reserpine; Sodium Chloride Symporter Inhibitors; Spironolactone; Vasodilator Agents | 1979 |
Changes in glomerular filtration rate during long term treatment with propranolol and peripheral vasodilators in patients with arterial hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Female; Glomerular Filtration Rate; Humans; Hydralazine; Hypertension; Male; Middle Aged; Prazosin; Propranolol; Time Factors; Vasodilator Agents | 1979 |
[The practitioner and drug-induced, predominantly orthostatic hypotension].
Topics: Adrenergic Agents; Adrenergic Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Antihypertensive Agents; Antipsychotic Agents; Barbiturates; Butyrophenones; Clonidine; Debrisoquin; Diazoxide; Diuretics; Ganglionic Blockers; Humans; Hydralazine; Hypotension, Orthostatic; Levodopa; Meprobamate; Methyldopa; Mineralocorticoids; Monoamine Oxidase Inhibitors; Phenothiazines; Prazosin; Psychotropic Drugs; Reserpine; Vasodilator Agents | 1978 |
Long-term outpatient vasodilator therapy of congestive heart failure. Consideration of agents at rest and during exercise.
Topics: Chronic Disease; Drug Therapy, Combination; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Hydralazine; Isosorbide Dinitrate; Lupus Erythematosus, Systemic; Nitroglycerin; Physical Exertion; Prazosin; Pressure; Rest; Time Factors; Vasodilator Agents | 1978 |
Afterload reduction in the treatment of cardiac failure.
Topics: Blood Pressure; Heart Failure; Humans; Hydralazine; Nitroglycerin; Nitroprusside; Phentolamine; Prazosin; Vasodilator Agents; Venous Pressure | 1978 |
[Vasodilator therapy of heart failure].
Topics: Heart Failure; Humans; Hydralazine; Nitrates; Nitroglycerin; Nitroprusside; Prazosin; Stroke Volume; Vascular Resistance; Vasodilator Agents | 1979 |
Nonparenteral vasodilator therapy for chronic congestive heart failure.
Topics: Heart Failure; Hemodynamics; Humans; Hydralazine; Nitrates; Nitroglycerin; Prazosin; Vasodilator Agents | 1979 |
Unimpaired beta adrenergic responses during prazosin administration.
Topics: Blood Glucose; Blood Pressure; Dopamine beta-Hydroxylase; Heart Rate; Humans; Hydralazine; Hypertension; Insulin; Prazosin; Quinazolines; Receptors, Adrenergic; Receptors, Adrenergic, beta; Renin | 1979 |
Hypotensive agents. Part I: Vasodilators.
Topics: Diazoxide; Humans; Hydralazine; Hypertension; Prazosin; Quinazolines | 1979 |
Afterload reduction in congestive heart failure.
Topics: Dopamine; Heart Failure; Humans; Hydralazine; Nitrates; Nitroglycerin; Nitroprusside; Phentolamine; Prazosin; Vasodilator Agents | 1978 |
Comparison of effects of tolmesoxide (RX71107), diazoxide, hydrallazine, prazosin, glyceryl trinitrate and sodium nitroprusside on forearm arteries and dorsal hand veins of man.
Topics: Adult; Antihypertensive Agents; Arteries; Blood Vessels; Diazoxide; Female; Forearm; Hand; Humans; Hydralazine; Male; Middle Aged; Nitroglycerin; Nitroprusside; Prazosin; Regional Blood Flow; Sulfoxides; Toluene; Vasodilation; Veins | 1978 |
Guidelines for evaluating and treating hypertension.
Topics: Aged; Antihypertensive Agents; Benzothiadiazines; Diuretics; Drug Therapy, Combination; Guanethidine; Humans; Hydralazine; Hypertension; Medical History Taking; Physical Examination; Prazosin; Propranolol; Sodium Chloride Symporter Inhibitors | 1979 |
When to use oral vasodilators for hypertension.
Topics: Administration, Oral; Diazoxide; Humans; Hydralazine; Hypertension; Minoxidil; Prazosin; Vasodilator Agents | 1979 |
Influence of vasodilators used in the therapy of heart failure on platelet aggregation.
Topics: Dihydralazine; Heart Failure; Humans; Hydralazine; In Vitro Techniques; Phentolamine; Platelet Aggregation; Prazosin; Time Factors; Vasodilator Agents | 1979 |
Contributions of hemodynamic monitoring to the treatment of chronic congestive heart failure.
Topics: Chronic Disease; Dobutamine; Dopamine; Heart; Heart Failure; Hemodynamics; Humans; Hydralazine; Monitoring, Physiologic; Nitrates; Nitroprusside; Phentolamine; Prazosin; Teprotide; Vasodilator Agents | 1979 |
Comparison of the in vitro effects of prazosin, nifedipine, and dihydralazine in isolated human mesenteric and crural vessels.
Topics: Adolescent; Adult; Aged; Calcium; Dihydralazine; Humans; Hydralazine; In Vitro Techniques; Leg; Mesenteric Arteries; Mesenteric Veins; Middle Aged; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Nifedipine; Norepinephrine; Potassium; Prazosin; Pyridines; Quinazolines | 1979 |
Comparison of haemodynamic effects of oral hydralazine and prazosin hydrochloride in patients with chronic congestive heart failure.
Topics: Adult; Aged; Cardiac Output; Chronic Disease; Female; Heart Failure; Hemodynamics; Humans; Hydralazine; Male; Middle Aged; Prazosin; Quinazolines; Vascular Resistance | 1979 |
Comparison of haemodynamic effects of oral prazosin, oral hydralazine, and intravenous nitroprusside in same patients with chronic heart failure.
Topics: Adult; Aged; Chronic Disease; Ferricyanides; Heart Failure; Hemodynamics; Humans; Hydralazine; Male; Middle Aged; Nitroprusside; Prazosin; Quinazolines | 1979 |
[Dihydralazin versus prazosin. The hemodynamic effect of the modul substances (author's transl)].
Topics: Animals; Blood Pressure; Cardiac Output; Cardiovascular System; Dihydralazine; Dogs; Heart Rate; Heart Ventricles; Hydralazine; Myocardial Contraction; Prazosin; Quinazolines; Stimulation, Chemical; Time Factors; Vascular Resistance | 1977 |
Hydralazine-induced tachycardia and sodium retention in heart failure. Hemodynamic and symptomatic correction by prazosin therapy.
Topics: Aged; Coronary Disease; Digitalis Glycosides; Female; Furosemide; Heart Failure; Humans; Hydralazine; Nitroprusside; Prazosin; Quinazolines; Sodium; Tachycardia | 1978 |
[Vasodilation treatment of heart insufficiency].
Topics: Heart Diseases; Humans; Hydralazine; Nitrites; Nitroprusside; Phentolamine; Prazosin; Vasodilator Agents | 1978 |
Vasodilator and inotropic therapy of heart failure [panel discussion].
Topics: Animals; Cardiac Output; Coronary Circulation; Dobutamine; Dogs; Dose-Response Relationship, Drug; Heart Failure; Humans; Hydralazine; Myocardial Contraction; Myocardial Infarction; Nitroprusside; Phentolamine; Prazosin; Propranolol; Vasoconstrictor Agents; Vasodilator Agents | 1978 |
Use of vasodilator drugs in congestive heart failure.
Topics: Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Nitroprusside; Prazosin; Vasodilator Agents | 1978 |
Workup and treatment of the average hypertensive patient.
Topics: Benzothiadiazines; Clonidine; Diuretics; Guanethidine; Humans; Hydralazine; Hypertension; Methyldopa; Minoxidil; Prazosin; Propranolol; Radiography; Renin; Reserpine; Sodium Chloride Symporter Inhibitors | 1978 |
[Peripheral vasodilators in the treatment of hypertension. A review].
Topics: Drug Therapy, Combination; Humans; Hydralazine; Hypertension; Prazosin; Quinazolines | 1979 |
Treatment of chronic essential hypertension.
Topics: Chlorothiazide; Clonidine; Diabetes Mellitus; Diet, Sodium-Restricted; Gout; Guanethidine; Humans; Hydralazine; Hypertension; Hypnotics and Sedatives; Medical History Taking; Methyldopa; Patient Compliance; Physical Examination; Phytotherapy; Plants, Medicinal; Potassium; Prazosin; Prognosis; Propranolol; Rauwolfia; Sympathectomy; Tranquilizing Agents | 1977 |
Mechanism of the hypotensive action of prazosin.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Diazoxide; Dose-Response Relationship, Drug; Drug Interactions; Epinephrine; Heart Rate; Hydralazine; Indoramin; Norepinephrine; Pentolinium Tartrate; Phentolamine; Prazosin; Quinazolines; Rats | 1977 |
Vasodilator therapy for acute heart failure: haemodynamic comparison of hydralazine/isosorbide, alpha-adrenoceptor blockade, and angiotensin-converting enzyme inhibition.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Cardiac Output, Low; Doxazosin; Drug Therapy, Combination; Enalaprilat; Heart Rate; Hemodynamics; Humans; Hydralazine; Injections, Intravenous; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Infarction; Prazosin; Pulmonary Wedge Pressure; Vasodilator Agents; Ventricular Function, Left | 1992 |
Aggravating action of hydralazine on ethanol-induced gastric lesions.
Topics: Animals; Captopril; Drug Interactions; Ethanol; Gastrointestinal Hemorrhage; Hydralazine; Male; Prazosin; Rats; Rats, Inbred Strains; Stomach; Stomach Diseases | 1992 |
Use of Tensiomin in hypertensive patients with impaired renal function.
Topics: Adult; Captopril; Creatinine; Humans; Hydralazine; Hypertension; Kidney; Kidney Failure, Chronic; Middle Aged; Prazosin; Renal Dialysis; Time Factors | 1992 |
First-choice antihypertensive drug use in the Glasgow Blood Pressure Clinic.
Topics: Adrenergic beta-Antagonists; Ambulatory Care Facilities; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Clonidine; Costs and Cost Analysis; Humans; Hydralazine; Hypertension; Methyldopa; Prazosin; Scotland | 1990 |
Modification of circadian blood pressure and heart rate variability by five different antihypertensive agents in spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Captopril; Circadian Rhythm; Clonidine; Heart Rate; Hydralazine; Hypertension; Male; Metoprolol; Prazosin; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 1991 |
PAF-induced bowel necrosis. Effects of vasodilators.
Topics: Alprostadil; Animals; Hydralazine; Hypotension; Indazoles; Intestinal Diseases; Leukopenia; Male; Mesenteric Arteries; Necrosis; Nitroglycerin; Phenoxybenzamine; Platelet Activating Factor; Prazosin; Rats; Rats, Inbred Strains; SRS-A; Vasodilator Agents | 1991 |
Atrial natriuretic factor-induced systemic vasoconstriction in conscious dogs, rats, and monkeys.
Topics: Adrenergic alpha-Antagonists; Animals; Atrial Natriuretic Factor; Consciousness; Dogs; Hemodynamics; Hydralazine; Macaca; Macaca fascicularis; Nitroglycerin; Prazosin; Rats; Rats, Inbred Strains; Renin; Vasoconstriction; Vasopressins | 1990 |
Effects of alpha 1- and alpha 2-adrenoceptor antagonists on venous tone in conscious rats.
Topics: Adrenergic alpha-Antagonists; Animals; Blood Pressure; Dose-Response Relationship, Drug; Heart Rate; Hexamethonium Compounds; Hydralazine; In Vitro Techniques; Male; Muscle Tonus; Muscle, Smooth, Vascular; Prazosin; Rats; Rats, Inbred Strains; Yohimbine | 1990 |
Effects of vasodilators on isolated human uteroplacental arteries.
Topics: Angiotensin II; Arteries; Chorionic Villi; Dinoprost; Female; Humans; Hydralazine; Labetalol; Nitrendipine; Norepinephrine; Potassium; Prazosin; Pregnancy; Uterus; Vasoconstriction; Vasodilator Agents; Vasopressins | 1991 |
Captopril increases norepinephrine spillover rate in conscious spontaneously hypertensive rats.
Topics: Animals; Blood Pressure; Captopril; Epinephrine; Heart Rate; Hydralazine; Infusions, Intravenous; Male; Norepinephrine; Prazosin; Rats; Rats, Inbred SHR | 1991 |
Effects of calcium channel blockers and hydralazine on plasma glucose levels in streptozotocin-induced diabetic rats in vivo.
Topics: Animals; Blood Glucose; Blood Pressure; Calcium Channel Blockers; Catecholamines; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Hexamethonium Compounds; Hydralazine; Male; Nicardipine; Nifedipine; Phentolamine; Prazosin; Propranolol; Rats; Rats, Inbred Strains; Starvation | 1990 |
Impact of a drug-use review program intervention on prescribing after publication of a randomized clinical trial.
Topics: Attitude of Health Personnel; Drug Prescriptions; Drug Utilization; Heart Failure; Hospitals, Veterans; Humans; Hydralazine; Information Theory; Isosorbide; Practice Patterns, Physicians'; Prazosin; Randomized Controlled Trials as Topic; Surveys and Questionnaires; United States | 1990 |
Role of the alpha-adrenergic blocking effect in the acute hypotensive effect of beta-adrenergic blocking drugs with alpha-blocking activities in conscious SHR.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Heart Rate; Hydralazine; Labetalol; Male; Prazosin; Propanolamines; Rats; Rats, Inbred SHR; Time Factors | 1985 |
Left ventricular hypertrophy in hypertensive patients.
Topics: Cardiomegaly; Drug Therapy, Combination; Humans; Hydralazine; Hypertension; Prazosin | 1989 |
Centrally acting alpha-2 agonists, peripherally acting adrenergic-blocking drugs, and direct vasodilators in the treatment of mild and moderate essential hypertension.
Topics: Adult; Aged; Black People; Clinical Protocols; Clonidine; Drug Therapy, Combination; Humans; Hydralazine; Hypertension; Methyldopa; Middle Aged; Prazosin | 1989 |
The differential effects of prazosin and hydralazine on sympathoadrenal activity in conscious rats.
Topics: Adrenal Glands; Animals; Blood Pressure; Catecholamines; Heart Rate; Hydralazine; Male; Norepinephrine; Prazosin; Rats; Rats, Inbred Strains; Sympathetic Nervous System | 1989 |
Clinical pharmacology of vasodilator drugs.
Topics: Adrenergic alpha-Antagonists; Calcium Channel Blockers; Coronary Disease; Humans; Hydralazine; Hypertension; Isosorbide Dinitrate; Kinetics; Liver; Muscle Contraction; Muscle, Smooth, Vascular; Nitroglycerin; Prazosin; Vasodilator Agents; Verapamil | 1985 |
[Hypertension in pregnancy: proposed monitoring and therapy].
Topics: Adrenergic beta-Antagonists; Captopril; Diuretics; Female; Follow-Up Studies; Humans; Hydralazine; Hypertension; Labetalol; Methyldopa; Prazosin; Pregnancy; Pregnancy Complications, Cardiovascular | 1985 |
Analysis of the mechanism underlying the vasodilator action of carvedilol in pithed spontaneously hypertensive rats.
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Carbazoles; Carvedilol; Decerebrate State; Dose-Response Relationship, Drug; Drug Interactions; Hydralazine; Hypertension; Labetalol; Prazosin; Propanolamines; Rats; Rats, Inbred SHR; Vasodilator Agents | 1988 |
Myocardial hypertrophy in rats with renal insufficiency.
Topics: Adenosine Triphosphatases; Animals; Blood Pressure; Blood Transfusion; Calcium; Cardiomegaly; Hydralazine; Isoenzymes; Kidney Diseases; Male; Metoprolol; Microscopy, Electron; Myocardium; Myosins; Nadolol; Nephrectomy; Organ Size; Parathyroid Glands; Prazosin; Propanolamines; Rats; Rats, Inbred Strains; Trifluoperazine | 1985 |
Effects of vasodilators on the coronary circulation in congestive heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Calcium Channel Blockers; Cardiomegaly; Cilazapril; Coronary Circulation; Heart Failure; Humans; Hydralazine; Nitroglycerin; Prazosin; Pyridazines; Vasodilator Agents | 1988 |
Current indications for vasodilator therapy for left ventricular failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Drug Therapy, Combination; Heart Failure; Hemodynamics; Humans; Hydralazine; Isosorbide Dinitrate; Minoxidil; Myocardial Infarction; Nitroprusside; Prazosin; Vasodilator Agents | 1985 |
Guidelines for vasodilator therapy of congestive heart failure in infants and children.
Topics: Captopril; Child; Child, Preschool; Enalapril; Heart Diseases; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Hydralazine; Infant; Nifedipine; Nitroglycerin; Nitroprusside; Phentolamine; Prazosin; Vasodilator Agents | 1987 |
Prostaglandins participate in the renal vasodilation due to hydralazine in dogs.
Topics: Animals; Blood Pressure; Cyclooxygenase Inhibitors; Dogs; Hydralazine; Indomethacin; Male; Prazosin; Prostaglandins; Renal Circulation; Vascular Resistance; Vasodilation | 1986 |
[Combined antihypertensive pharmacotherapy].
Topics: Adult; Antihypertensive Agents; Drug Combinations; Drug Evaluation; Drug Therapy, Combination; Female; Hemodynamics; Humans; Hydralazine; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Prazosin; Reserpine; Time Factors | 1988 |
[Current management of left heart failure].
Topics: Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Agents; Catecholamines; Digitalis Glycosides; Diuretics; Heart Failure; Humans; Hydralazine; Nitrites; Phosphodiesterase Inhibitors; Prazosin | 1987 |
System approach to testing hypotensive drugs for prevention of arterial hypertension.
Topics: Clinical Trials as Topic; Humans; Hydralazine; Hyperlipidemias; Hypertension; Prazosin; Propranolol | 1987 |
[Efficacy of a graded plan for long-term prevention using antihypertensive drugs. Work Group for the Cooperative Study for the Testing of New Preparations for the Prevention of Arterial Hypertension (CSPPAH)].
Topics: Adult; Antihypertensive Agents; Blood Pressure; Diastole; Drug Therapy, Combination; Heart Rate; Humans; Hydralazine; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Prazosin; Propranolol; Systole | 1987 |
[Interaction of digoxin with hydralazine and prazosin].
Topics: Adult; Digoxin; Drug Interactions; Drug Therapy, Combination; Humans; Hydralazine; Hypertension; Male; Middle Aged; Prazosin | 1986 |
Comparative effects of vasodilator drugs on flow distribution and venous return.
Topics: Animals; Blood Pressure; Captopril; Dogs; Hemodynamics; Hydralazine; Models, Biological; Nifedipine; Prazosin; Regional Blood Flow; Time Factors; Vascular Resistance; Vasodilator Agents | 1985 |
[Vasodilator agents in chronic asymptomatic aortic insufficiency: echocardiographic study].
Topics: Adult; Aged; Aortic Valve Insufficiency; Captopril; Chronic Disease; Echocardiography; Female; Hemodynamics; Humans; Hydralazine; Male; Middle Aged; Prazosin | 1985 |
Treatment of congestive heart failure by altering loading conditions of the heart.
Topics: Captopril; Cardiac Output; Child; Digoxin; Dopamine; Drug Therapy, Combination; Heart; Heart Failure; Humans; Hydralazine; Infant; Infant, Newborn; Nitroglycerin; Nitroprusside; Prazosin; Vasodilator Agents | 1985 |
Vasodilator therapy for chronic congestive heart failure.
Topics: Captopril; Cardiac Catheterization; Heart Failure; Hospitalization; Humans; Hydralazine; Myocardial Contraction; Nitrates; Nitroglycerin; Prazosin; Pressure; Vascular Resistance; Vasodilator Agents; Veins | 1985 |
Serial measurements of systolic time intervals during treatment with hydrochlorothiazide alone and combined with other antihypertensive agents.
Topics: Antihypertensive Agents; Drug Therapy, Combination; Electrocardiography; Humans; Hydralazine; Hydrochlorothiazide; Hypertension; Male; Myocardial Contraction; Oxprenolol; Prazosin; Propranolol; Systole; Time Factors | 1985 |
Diagnosis and management of malignant hypertension.
Topics: Antihypertensive Agents; Female; Humans; Hydralazine; Hypertension, Malignant; Kidney Function Tests; Male; Methyldopa; Minoxidil; Nitroprusside; Phentolamine; Prazosin; Pregnancy; Pregnancy Complications, Cardiovascular; Propranolol; Reserpine; Retinal Hemorrhage; Retinal Vessels; Trimethaphan | 1985 |
[Hypotensive effect and tolerability of a short course of treatment with prazosin (pratsiol) and hydralazine (apressin) in a cooperative study of new drugs for the prevention of arterial hypertension].
Topics: Adult; Drug Therapy, Combination; Humans; Hydralazine; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Prazosin; Quinazolines; Time Factors | 1985 |
Combined prazosin and hydralazine in resistant hypertension.
Topics: Adult; Blood Pressure; Drug Therapy, Combination; Female; Humans; Hydralazine; Hypertension; Male; Middle Aged; Posture; Prazosin; Quinazolines | 1980 |
Current trends in the management of hypertension.
Topics: Adrenergic beta-Antagonists; Aged; Diazoxide; Diuretics; Female; Humans; Hydralazine; Hypertension; Male; Methyldopa; Middle Aged; Minoxidil; Nitroprusside; Prazosin; Risk; Vasodilator Agents | 1980 |
Adverse drug reactions to antihypertensive therapy.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Benzothiadiazines; Clonidine; Diuretics; Humans; Hydralazine; Hypertension; Methyldopa; Physician-Patient Relations; Prazosin; Sodium Chloride Symporter Inhibitors | 1980 |
What patients with hypertension should know about their medication.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Clonidine; Diuretics; Humans; Hydralazine; Hypertension; Methyldopa; Patient Education as Topic; Prazosin; Sympatholytics | 1980 |
[Vasodilators in heart failure? Basic principles and its role in practice].
Topics: Adrenergic alpha-Antagonists; Captopril; Diazoxide; Furosemide; Heart Failure; Humans; Hydralazine; Minoxidil; Phentolamine; Prazosin; Vasodilator Agents | 1981 |
Reduction in norepinephrine content of sympathetic neuroeffector organs by alpha adrenergic antagonists and nerve stimulation: evidence for presynaptic control of sympathetic transmitter release in intact animal.
Topics: Adrenergic alpha-Antagonists; Animals; Bretylium Compounds; Heart; Hydralazine; Male; Norepinephrine; Phentolamine; Prazosin; Rats; Receptors, Adrenergic, alpha; Salivary Glands; Sodium Chloride; Spleen; Sympathetic Nervous System; Synaptic Transmission; Yohimbine | 1984 |
Sexual dysfunction due to antihypertensive agents.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Benzothiadiazines; Clonidine; Diuretics; Female; Guanethidine; Humans; Hydralazine; Male; Methyldopa; Prazosin; Propranolol; Reserpine; Sex; Sexual Dysfunction, Physiological; Sodium Chloride Symporter Inhibitors; Spironolactone | 1984 |
Office management of hypertension.
Topics: Adrenergic beta-Antagonists; Aged; Ambulatory Care; Antihypertensive Agents; Benzothiadiazines; Captopril; Clonidine; Diuretics; Guanabenz; Humans; Hydralazine; Hypertension; Methyldopa; Middle Aged; Prazosin; Reserpine; Sodium Chloride Symporter Inhibitors | 1984 |
Hypertension: special concerns in geriatric patients.
Topics: Adrenergic beta-Antagonists; Aged; Aging; Calcium Channel Blockers; Captopril; Diet, Sodium-Restricted; Diuretics; Humans; Hydralazine; Hypertension; Patient Compliance; Prazosin; Sympatholytics | 1984 |
Neuropsychiatric manifestations of antihypertensive medications.
Topics: Adrenergic beta-Antagonists; Affective Symptoms; Antihypertensive Agents; Benzothiadiazines; Clonidine; Diuretics; Furosemide; Guanethidine; Humans; Hydralazine; Hypertension; Methyldopa; Prazosin; Secologanin Tryptamine Alkaloids; Sodium Chloride Symporter Inhibitors | 1983 |
[Alternatives to digitalis therapy?].
Topics: Albuterol; Captopril; Dobutamine; Dopamine; Heart Failure; Humans; Hydralazine; Nitrates; Prazosin; Teprotide | 1981 |
Pharmacological evidence for a functional role of the prejunctional alpha-adrenoreceptor in noradrenergic neurotransmission in the conscious rat.
Topics: Animals; Blood Pressure; Handling, Psychological; Heart Rate; Hydralazine; In Vitro Techniques; Male; Norepinephrine; Phenoxybenzamine; Phentolamine; Prazosin; Rats; Receptors, Adrenergic; Receptors, Adrenergic, alpha; Synaptic Transmission; Yohimbine | 1980 |
Treatment of acute and chronic congestive heart failure by vasodilator-afterload reduction.
Topics: Acute Disease; Antihypertensive Agents; Blood Pressure; Cardiac Output; Chronic Disease; Diastole; Heart Failure; Humans; Hydralazine; Muscle, Smooth, Vascular; Nitroprusside; Phentolamine; Prazosin; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Vasodilator Agents; Venous Pressure | 1980 |
[Vasodilating agents in the treatment of hypertension - a review].
Topics: Diazoxide; Humans; Hydralazine; Hypertension; Minoxidil; Nitroprusside; Prazosin; Synaptic Transmission; Vasodilator Agents | 1981 |
Discriminative stimulus properties of the vasodilator, hydralazine: differential generalization with alpha 1 and alpha 2 adrenoreceptor drugs.
Topics: Animals; Blood Pressure; Clonidine; Conditioning, Operant; Discrimination Learning; Dose-Response Relationship, Drug; Generalization, Stimulus; Hydralazine; Male; Prazosin; Rats; Rats, Inbred Strains; Receptors, Adrenergic; Receptors, Adrenergic, alpha | 1982 |
Captopril in congestive heart failure: improved left ventricular function with decreased metabolic cost.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Hydralazine; Hypotension; Myocardium; Oxygen Consumption; Prazosin; Proline; Vasodilator Agents | 1982 |
[Antihypertensive vasodilators].
Topics: Antihypertensive Agents; Chemical Phenomena; Chemistry; Diazoxide; Dihydralazine; Humans; Hydralazine; Minoxidil; Nitroprusside; Prazosin; Vasodilator Agents | 1983 |
Correction of dilutional hyponatremia in severe chronic heart failure by converting-enzyme inhibition.
Topics: Adult; Aged; Aminopyridines; Amrinone; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiotonic Agents; Female; Heart Failure; Hemodynamics; Humans; Hydralazine; Hyponatremia; Male; Middle Aged; Prazosin; Proline | 1984 |
Vasodilator therapy for acute myocardial infarction and chronic congestive heart failure.
Topics: Captopril; Heart Failure; Hemodynamics; Humans; Hydralazine; Myocardial Infarction; Prazosin; Regional Blood Flow; Vasoconstriction; Vasodilator Agents | 1983 |
New approaches to managing congestive heart failure.
Topics: Captopril; Heart Failure; Humans; Hydralazine; Prazosin; Proline; Quinazolines | 1983 |
[Alternatives to digitalis therapy].
Topics: Aminopyridines; Amrinone; Captopril; Catecholamines; Diuretics; Heart Failure; Humans; Hydralazine; Nitrates; Nitroprusside; Practolol; Prazosin; Prenalterol; Vasodilator Agents | 1983 |
Chronic afterload reduction in the treatment of congestive heart failure.
Topics: Captopril; Drug Evaluation; Heart Failure; Humans; Hydralazine; Prazosin; Proline; Quinazolines | 1983 |
Vasodilator therapy in children: acute and chronic effects in children with left ventricular dysfunction or mitral regurgitation.
Topics: Adolescent; Captopril; Cardiac Catheterization; Child; Child, Preschool; Digoxin; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Hydralazine; Infant; Mitral Valve Insufficiency; Prazosin; Time Factors; Vasodilator Agents | 1984 |
Vasodilators for chronic congestive heart failure.
Topics: Captopril; Heart Failure; Humans; Hydralazine; Nitrates; Prazosin; Vasodilator Agents | 1984 |
Chronic heart failure in the elderly: vasodilator therapy.
Topics: Aged; Blood Pressure; Chronic Disease; Female; Follow-Up Studies; Heart Failure; Humans; Hydralazine; Male; Minoxidil; Nitroglycerin; Prazosin; Sinoatrial Node; Vasodilator Agents | 1983 |
Vasodilators in the treatment of congestive heart failure.
Topics: Captopril; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Minoxidil; Nitroglycerin; Nitroprusside; Prazosin; Vasodilator Agents | 1983 |
Vasodilator drugs.
Topics: Calcium Channel Blockers; Captopril; Heart Failure; Humans; Hydralazine; Minoxidil; Nitroglycerin; Nitroprusside; Phentolamine; Prazosin; Thiocyanates; Vasodilator Agents | 1984 |
Vasodilators and ventricular septal defect: comparison of prazosin, minoxidil, and hydralazine in a chronic lamb model.
Topics: Animals; Blood Pressure; Heart Rate; Heart Septal Defects, Ventricular; Hydralazine; Minoxidil; Prazosin; Pulmonary Circulation; Pyrimidines; Quinazolines; Sheep; Vascular Resistance; Vasodilation | 1984 |
Differences in blood pressure lowering effects in PGs following indirect and direct blood pressure measurements.
Topics: Alprostadil; Animals; Blood Pressure; Blood Pressure Determination; Dinoprostone; Hydralazine; Male; Prazosin; Prostaglandins; Prostaglandins E; Rats; Rats, Inbred SHR | 1984 |
[Causes of acute valve-conditioned left ventricular insufficiency-- attempt at a tabulated review].
Topics: Aortic Valve Insufficiency; Cardiac Glycosides; Dyspnea; Endocarditis, Bacterial; Humans; Hydralazine; Hypertension; Mitral Valve Insufficiency; Mitral Valve Prolapse; Nitroprusside; Prazosin; Pulmonary Edema | 1984 |
Contrasting hemodynamic responses in severe heart failure: comparison of captopril and other vasodilator drugs.
Topics: Adult; Aged; Captopril; Female; Heart Failure; Hemodynamics; Humans; Hydralazine; Isosorbide Dinitrate; Lung; Male; Middle Aged; Nitroprusside; Prazosin; Proline; Vascular Resistance; Vasodilation; Vasodilator Agents | 1982 |
Vasodilators in the treatment of hypertension.
Topics: Calcium Channel Blockers; Captopril; Diazoxide; Humans; Hydralazine; Hypertension; Minoxidil; Nitroprusside; Prazosin; Vasodilator Agents | 1982 |
Pharmacodynamic basis of the use of vasodilators in the treatment of heart failure.
Topics: Cardiac Output; Diuretics; Heart Failure; Hemodynamics; Humans; Hydralazine; Myocardial Contraction; Nitroglycerin; Phentolamine; Prazosin; Vasodilator Agents | 1980 |
The role of vasodilator therapy in the management of the patient with acute myocardial infarction.
Topics: Heart Failure; Heart Rupture; Hemodynamics; Humans; Hydralazine; Mitral Valve Insufficiency; Myocardial Infarction; Nitroglycerin; Nitroprusside; Prazosin; Vasodilator Agents | 1981 |
Vasodilator therapy in refractory congestive heart failure: a comparative analysis of hemodynamic and noninvasive studies.
Topics: Aged; Cardiac Output; Drug Evaluation; Echocardiography; Female; Heart Failure; Hemodynamics; Humans; Hydralazine; Isosorbide Dinitrate; Male; Middle Aged; Nitroglycerin; Ointment Bases; Prazosin; Pulmonary Wedge Pressure; Stroke Volume; Vasodilator Agents | 1982 |
Preload and afterload without anguish: a simplified framework.
Topics: Cardiac Output; Coronary Circulation; Heart Failure; Heart Function Tests; Humans; Hydralazine; Nitrates; Nitroglycerin; Nitroprusside; Prazosin; Pulmonary Wedge Pressure; Stroke Volume; Vascular Resistance; Vasodilator Agents | 1982 |
A review of the long-term effects of prazosin and hydralazine in chronic congestive heart failure.
Topics: Chronic Disease; Drug Therapy, Combination; Follow-Up Studies; Heart Failure; Humans; Hydralazine; Nitrates; Prazosin; Quinazolines; Spironolactone; Time Factors | 1983 |
What to watch for with peripherally acting antihypertensives.
Topics: Antihypertensive Agents; Diazoxide; Drug Interactions; Humans; Hydralazine; Nitroprusside; Prazosin | 1980 |
Hydralazine in chronic CHF.
Topics: Administration, Oral; Aortic Valve Insufficiency; Cardiac Output; Chronic Disease; Drug Therapy, Combination; Heart Failure; Heart Rate; Hemodynamics; Humans; Hydralazine; Hypertension; Mitral Valve Insufficiency; Myocardial Contraction; Nitrates; Prazosin; Stroke Volume; Vascular Resistance | 1981 |
Prostaglandin synthesis by vascular smooth muscle cells is stimulated by bradykinin, prazosin and hydralazine.
Topics: Animals; Aorta; Bradykinin; Cells, Cultured; Dinoprostone; Guinea Pigs; Hydralazine; Muscle, Smooth, Vascular; Prazosin; Prostaglandins; Prostaglandins E; Quinazolines | 1981 |
Hemodynamic and metabolic effects of vasodilators, nitrates, hydralazine, prazosin and captopril in chronic ischemic heart failure.
Topics: Captopril; Coronary Disease; Hemodynamics; Humans; Hydralazine; Isosorbide Dinitrate; Lactates; Myocardium; Oxygen Consumption; Prazosin; Vasodilator Agents | 1981 |
Changes in control of renin release in congestive heart failure in dogs: response to acute and chronic vasodilator therapy.
Topics: Animals; Blood Pressure; Blood Volume; Dogs; Heart Failure; Heart Rate; Hydralazine; Myocardial Infarction; Nitroprusside; Prazosin; Renin; Vasodilator Agents | 1982 |
Vasodilators in heart failure secondary to coronary artery disease.
Topics: Cardiac Output; Coronary Disease; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Myocardium; Oxygen Consumption; Prazosin; Pulmonary Wedge Pressure; Time Factors; Vasodilator Agents | 1982 |
The addition of prazosin to standard triple therapy in the treatment of severe hypertension.
Topics: Adult; Aged; Bendroflumethiazide; Blood Pressure; Drug Therapy, Combination; Electrocardiography; Female; Humans; Hydralazine; Hypertension; Male; Middle Aged; Prazosin; Propranolol; Quinazolines | 1982 |
Pharmacologic approach to the management of childhood hypertension.
Topics: Antihypertensive Agents; Autonomic Nervous System; Central Nervous System; Child; Diazoxide; Humans; Hydralazine; Hypertension; Minoxidil; Muscle, Smooth, Vascular; Nitroprusside; Prazosin; Receptors, Adrenergic | 1981 |
Comparison of hypotensive, orthostatic and sympathetic inhibitory actions of antihypertensive drugs in rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Clonidine; Diazepam; Guanethidine; Heart Rate; Hydralazine; Hypotension; Male; Mecamylamine; Methyldopa; Minoxidil; Phentolamine; Posture; Prazosin; Propranolol; Rats; Reserpine; Sympathetic Nervous System | 1981 |
Correlation between decreased heart rate and central inhibition of sympathetic discharge after prazosin administration in the spontaneously hypertensive rat.
Topics: Animals; Blood Pressure; Cardiovascular System; Heart Rate; Hydralazine; Hypertension; Male; Prazosin; Quinazolines; Rats; Sympathetic Nervous System | 1981 |
Dynamic responses to continuous use of prazosin and hydralazine in patients with refractory heart failure.
Topics: Aged; Blood Pressure; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Hydralazine; Male; Middle Aged; Prazosin; Quinazolines; Vascular Resistance | 1981 |
Prazosin and hydralazine in congestive heart failure. Regional hemodynamic effects in relation to dose.
Topics: Cardiac Output; Dose-Response Relationship, Drug; Female; Heart Failure; Hemodynamics; Humans; Hydralazine; Kidney; Liver Circulation; Male; Middle Aged; Prazosin; Quinazolines; Regional Blood Flow; Vascular Resistance | 1981 |
[Antihypertensive activity of minoxidil, hydralazine, prazosin, phentolamine and clonidine in spontaneously hypertensive rats. Comparison with therapeutic dosages].
Topics: Animals; Antihypertensive Agents; Clonidine; Hydralazine; Hypertension; Minoxidil; Phentolamine; Prazosin; Rats | 1981 |
[Limitations of long-term treatment with vasodilator agents in increasing maximum functional capacity in patients with left ventricular insufficiency].
Topics: Exercise Test; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Hydralazine; Male; Middle Aged; Myocardial Contraction; Myocardium; Oxygen Consumption; Prazosin; Vasodilator Agents | 1981 |
Is there a drug of choice for vasodilator therapy in patients with refractory heart failure?
Topics: Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Phentolamine; Prazosin; Vasodilator Agents | 1980 |
New therapies in the management of congestive heart failure.
Topics: Heart Failure; Humans; Hydralazine; Prazosin; Quinazolines | 1980 |
New approaches to therapy of acute heart failure.
Topics: Antihypertensive Agents; Dobutamine; Heart Failure; Humans; Hydralazine; Nitrates; Nitroprusside; Oxygen Inhalation Therapy; Prazosin | 1980 |
Metabolic assessment of exercise in chronic heart failure patients treated with short-term vasodilators.
Topics: Adult; Aged; Cardiac Output; Energy Metabolism; Heart Failure; Hemodynamics; Humans; Hydralazine; Lactates; Middle Aged; Myocardium; Oxygen Consumption; Physical Exertion; Prazosin; Quinazolines | 1980 |
Beneficial effects of afterload reduction therapy in patients with congestive heart failure and moderate aortic stenosis.
Topics: Adult; Aged; Aortic Valve Stenosis; Blood Pressure; Cardiac Output; Female; Heart Failure; Heart Rate; Humans; Hydralazine; Male; Middle Aged; Prazosin; Quinazolines; Stroke Volume; Vascular Resistance; Vasodilator Agents | 1980 |
Vasodilator therapy of chronic congestive heart failure.
Topics: Ambulatory Care; Chronic Disease; Heart Failure; Humans; Hydralazine; Nitrates; Prazosin; Quinazolines | 1980 |
Special considerations in treating hypertension in the elderly.
Topics: Aged; Clonidine; Diet, Sodium-Restricted; Diuretics; Guanethidine; Humans; Hydralazine; Hypertension; Methyldopa; Prazosin | 1980 |
Effect of vasodilator drugs on exercise performance in cardiac failure. Comparison of hydralazine and prazosin.
Topics: Adult; Aged; Female; Heart Failure; Hemodynamics; Humans; Hydralazine; Male; Middle Aged; Oxygen Consumption; Physical Exertion; Prazosin; Quinazolines; Respiration | 1980 |
Vasodilator drugs and resistant hypertension.
Topics: Antihypertensive Agents; Diazoxide; Drug Therapy, Combination; Humans; Hydralazine; Hypertension; Minoxidil; Prazosin; Vasodilator Agents | 1980 |
Positive inotropic effects of hydralazine in human subjects: comparison with prazosin in the setting of congestive heart failure.
Topics: Dose-Response Relationship, Drug; Heart Failure; Heart Rate; Humans; Hydralazine; Myocardial Contraction; Prazosin; Pulmonary Wedge Pressure; Quinazolines; Stroke Volume | 1980 |
[Treatment of cardiac insufficiency with systemic vasodilator agents].
Topics: Heart Failure; Hemodynamics; Humans; Hydralazine; Nitrites; Nitroprusside; Prazosin; Vasodilator Agents | 1980 |
Complications of antihypertensive therapy.
Topics: Antihypertensive Agents; Benzothiadiazines; Clonidine; Diuretics; Female; Guanethidine; Humans; Hydralazine; Hyperglycemia; Hypertension; Hypokalemia; Male; Methyldopa; Minoxidil; Prazosin; Propranolol; Reserpine; Sodium Chloride Symporter Inhibitors; Uric Acid | 1981 |
Vasodilator therapy in primary pulmonary hypertension.
Topics: Adult; Diazoxide; Female; Hemodynamics; Humans; Hydralazine; Hypertension, Pulmonary; Isoproterenol; Male; Phentolamine; Physical Exertion; Prazosin; Pulmonary Circulation; Vasodilator Agents | 1981 |
Effect of vasoactive drugs on tumour blood flow as determined by 2H nuclear magnetic resonance spectroscopy.
Topics: Animals; Blood Pressure; Body Water; Calcitonin Gene-Related Peptide; Cell Hypoxia; Deuterium; Deuterium Oxide; Dose-Response Relationship, Drug; Fibrosarcoma; Hydralazine; Hyperthermia, Induced; Magnetic Resonance Spectroscopy; Prazosin; Rats; Rats, Inbred Strains; Regional Blood Flow; Time Factors | 1995 |
Modulation of renal vasoconstrictor effect of NG-nitro-L-arginine in rabbit by angiotensin II and alpha-1 adrenergic receptor blockade.
Topics: Adrenergic alpha-Antagonists; Angiotensin II; Animals; Antibodies; Arginine; Biphenyl Compounds; Drug Interactions; Hemodynamics; Hydralazine; Imidazoles; Kidney; Losartan; Male; Nitroarginine; Prazosin; Rabbits; Tetrazoles; Vasoconstrictor Agents | 1994 |
Hypertriglyceridemia in experimental diabetes: relationship to cardiac dysfunction.
Topics: Animals; Antihypertensive Agents; Blood Glucose; Cholesterol; Clofibrate; Diabetes Mellitus, Experimental; Dichloroacetic Acid; Heart; Heart Diseases; Hydralazine; Hypertriglyceridemia; In Vitro Techniques; Insulin; Lipids; Male; Palmitates; Prazosin; Rats; Rats, Wistar; Triglycerides; Verapamil | 1994 |
TxA2-PGI2-PGF2 alfa responses in the kidney to blood pressure reduction induced by vasodilator/vasorelaxing agents with different action in patients with essential hypertension.
Topics: Adolescent; Adult; Blood Pressure; Dinoprost; Epoprostenol; Female; Gallopamil; Glomerular Filtration Rate; Humans; Hydralazine; Hypertension; Kidney; Male; Middle Aged; Prazosin; Prostaglandins; Sodium; Thromboxane A2; Vasodilator Agents; Venous Pressure | 1993 |
Angiotensin II alters aortic fibronectin independently of hypertension.
Topics: Angiotensin II; Animals; Aorta; Biphenyl Compounds; Blood Pressure; Fibronectins; Humans; Hydralazine; Hypertension; Imidazoles; Losartan; Male; Prazosin; Rats; Rats, Wistar; RNA, Messenger; Tetrazoles | 1994 |
REM sleep inhibition by desipramine: evidence for an alpha-1 adrenergic mechanism.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adrenergic Uptake Inhibitors; Animals; Antihypertensive Agents; Cats; Desipramine; Female; Hydralazine; Prazosin; Propranolol; Sleep, REM | 1995 |
Effects of antihypertensive drugs on rat tissue antioxidant enzyme activities and lipid peroxidation levels.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Captopril; Enzyme Activation; Heart; Hydralazine; Lipid Peroxidation; Liver; Muscle, Skeletal; Myocardium; Prazosin; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances | 1997 |
Hemodynamic changes during administration of drugs for mitral regurgitation in dogs.
Topics: Animals; Captopril; Cardiotonic Agents; Digoxin; Dog Diseases; Dogs; Echocardiography, Doppler, Color; Enalapril; Hemodynamics; Hydralazine; Mitral Valve Insufficiency; Prazosin; Vasodilator Agents | 1998 |
Interaction between isoniazid and diverse vasodilators: role of decreased cerebral GABA.
Topics: Animals; Blood Pressure; Captopril; Dipyridamole; Drug Synergism; gamma-Aminobutyric Acid; Guanidines; Heart Rate; Hydralazine; Hypothalamus; Isoniazid; Male; Minoxidil; Pinacidil; Pons; Prazosin; Rats; Rats, Wistar; Vasodilator Agents | 1998 |
Antihypertensive mechanisms underlying a novel salt-sensitive hypertensive model induced by sensory denervation.
Topics: Animals; Animals, Newborn; Antihypertensive Agents; Blood Pressure; Body Weight; Calcitonin Gene-Related Peptide; Capsaicin; Diuresis; Ganglia, Spinal; Hydralazine; Hypertension; Losartan; Male; Nerve Degeneration; Neurons, Afferent; Potassium; Prazosin; Rats; Rats, Wistar; Sodium; Sodium, Dietary | 1999 |
Optimal frequency ranges for extracting information on cardiovascular autonomic control from the blood pressure and pulse interval spectrograms in mice.
Topics: Animals; Atenolol; Atropine; Autonomic Nervous System; Blood Pressure; Cardiovascular Physiological Phenomena; Heart Rate; Hydralazine; Male; Mice; Mice, Inbred C57BL; Parasympathomimetics; Prazosin; Signal Processing, Computer-Assisted; Sympatholytics; Telemetry; Vasodilation; Vasodilator Agents | 2007 |
Applicability of recent methods used to estimate spontaneous baroreflex sensitivity to resting mice.
Topics: Algorithms; Animals; Antihypertensive Agents; Atenolol; Atropine; Baroreflex; Blood Pressure; Fourier Analysis; Hydralazine; Male; Mice; Mice, Inbred C57BL; Parasympatholytics; Prazosin; Pulse; Rest | 2008 |
Posterior reversible encephalopathy syndrome.
Topics: Adult; Anticonvulsants; Antihypertensive Agents; Diagnosis, Differential; Drug Therapy, Combination; Electroencephalography; Female; Humans; Hydralazine; Magnetic Resonance Imaging; Phenytoin; Posterior Leukoencephalopathy Syndrome; Prazosin; Puerperal Disorders | 2012 |
Involvement of renal sympathetic nerve overactivation in the progression of chronic kidney disease in rats.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Autonomic Nervous System Diseases; Blood Pressure; Disease Progression; GABA Agents; gamma-Aminobutyric Acid; Hydralazine; Kidney; Kidney Function Tests; Male; Nephrectomy; Norepinephrine; Peripheral Nerves; Prazosin; Propranolol; Rats; Rats, Sprague-Dawley; Renal Insufficiency, Chronic; Sympathetic Nervous System | 2014 |